Cargando…

OR05-6 The Effect of the GLP1R Variant rs6923761 on Post-Prandial Glucose Levels during Treatment with Sitagliptin

BACKGROUND: Glucagon-like peptide-1 (GLP-1) functions to increase insulin production in a glucose-dependent manner. Endogenous GLP-1 is rapidly degraded by the enzyme dipeptidyl peptidase 4 (DPP4), and GLP-1 receptor agonists and DPP4 inhibitors (DPP4Is) are now used in the treatment of diabetes. Th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mashayekhi, Mona, Wilson, Jessica, Jafarian-Kerman, Scott, Brown, Nancy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Diabetes Mellitus and Glucose Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6555090/ http://dx.doi.org/10.1210/js.2019-OR05-6

Ejemplares similares

MON-663 Prandial Insulin Dosing Based on Carbohydrate Content Does Not Significantly Improve Glycemic Control in Hospitalized Patients with Diabetes
por: Goel, Heenam, et al.
Publicado: (2020)

SAT-LB026 Basal-Prandial Insulin versus Basal-Sliding-Scale Insulin in the Management of Hyperglycemia in Non-Critically Ill Hospitalized Patients
por: Malkhasyan, Victoria, et al.
Publicado: (2019)

SAT-662 Effects of SGLT Inhibitors or GLP1 Analogues on Glucose Homeostasis and Body Weight in Patients with Type 1 Diabetes: A Network Meta-Analysis
por: Lim, Soo, et al.
Publicado: (2020)

SAT-139 Clinical Impact of Oral Semaglutide Compared with Sitagliptin in T2D on Metformin ± Sulfonylurea: The Pioneer 3 Trial
por: Rosenstock, Julio, et al.
Publicado: (2019)

Management of Late Dumping Syndrome Induced Hypoglycemia With GLP-1R Agonist
por: Shaghouli, Amna Ali, et al.
Publicado: (2021)

LBSUN306 Effects Of Glp-1 Receptor Agonism, Dpp4 Inhibition, And Hypocaloric Diet On Metabolic Parameters In Obese Pre-diabetic Individuals: A Randomized-controlled Trial
por: Mashayekhi, Mona, et al.
Publicado: (2022)

SUN-148 Are Glp Analogues Superior For Diabetes And Weight Control In Patients On Antidepressant Medications?
por: Azim, Salman, et al.
Publicado: (2019)

MON-666 Glucokinase Within the Hypothalamic Paraventricular Nucleus Is Important in GLP-1 Release
por: Ratnasabapathy, Risheka
Publicado: (2020)

OR26-05 The Correction Factor for A1C in Anemic Patients
por: Villacreses, Maria Chang, et al.
Publicado: (2020)

MON-LB028 Comparing Cardiovascular Effects of GLP-1 Agonists in a Real World Setting
por: Wallia, Amisha, et al.
Publicado: (2019)

SAT-LB030 Efficacy of Combined Therapy with Metformin and Sitagliptin in Patients with Type 2 Diabetes Who Did Not Reach Target Levels of Glycated Hemoglobin on Metformin Monotherapy
por: Klitsunova, Yuliia, et al.
Publicado: (2019)

Do GLP-1 Receptor Agonists Increase the Risk of Breast Cancer? A Systematic Review and Meta-Analysis
por: Piccoli, Giovana Fagundes, et al.
Publicado: (2021)

MON-646 Novel Use of GLP-1 Receptor Agonist Therapy in MODY-1 (HNF4A Mutation)
por: Broome, David Tyler, et al.
Publicado: (2020)

OR05-4 Androgen Induced Metabolic Dysfunction in Female Mice is Prevented by Deletion of Liver Androgen Receptor
por: Wu, Sheng, et al.
Publicado: (2019)

OR08-05 Sex and Ethnic Differences in Advanced Lipoprotein Profiles in South Asians, African-Americans, and Caucasians
por: Sarcone, Camila, et al.
Publicado: (2020)

ODP238 RELATIONSHIP BETWEEN BODY COMPOSITION, POST PRANDIAL GLUCOSE AND INSULIN FOR EARLY PREDICTION OF TYPE 2 DIABETES AND CARDIOVASCULAR RISK.
por: Moya, Elena Amoroso, et al.
Publicado: (2022)

MON-130 Optimal Glycemic Control in a Patient with HNF1A MODY with GLP1-RA Monotherapy: Implications for Future Therapy
por: Fantasia, Kathryn, et al.
Publicado: (2019)

A Point-of-Care Interactive Decision Tool Reveals Variance Between Clinicians and Experts in Selecting Among GLP-1 RAs in T2D
por: Schwartz, Zachary, et al.
Publicado: (2021)

OR05-2 Targeted Inhibition of Glutamate Dehydrogenase by Alpha-Tocopherol: A Potential Novel Treatment for Hyperinsulinism Hyperammonemia Syndrome
por: Rosenfeld, Elizabeth, et al.
Publicado: (2019)

SUN-121 Vitamin D Repletion and Sitagliptin Administration is Associated with an Increase in Serum C-Peptide and a Decrease in GAD-65 Antibody and Hemoglobin A1c in a Patient with Latent Autoimmune Diabetes of Adults
por: Fox, Nicholette, et al.
Publicado: (2019)

Efficient Restoration of Beta Cell Dedifferentiation by Calorie Restriction With High Fat/Low Carbohydrate Diet in Obese Diabetes Model and the Possible Role of GLP-1
por: Ishida, Emi, et al.
Publicado: (2021)

OR14-05 Hepatocyte Peroxisome Proliferator-Activated Receptor Gamma (PPARG) Offsets the Anti-Steatogenic Effects of Thiazolidinediones in Obese Male Mice
por: Muratalla, Jose T, et al.
Publicado: (2020)

SUN-165 The Largest Single-Center Experience of GLP-1 Receptor Agonists as a Safe and Effective Agent for the Management of Diabetes in Solid Organ Transplant (SOT) Recipients
por: Singh, Priyamvada, et al.
Publicado: (2019)

OR05-3 Mir-21 Contributes to Cytokine-Induced Beta Cell Dysfunction via Inhibition of mRNAs Regulating Beta Cell Identity
por: Ibrahim, Sara, et al.
Publicado: (2019)

SAT-635 Results of a Preclinical Pilot Study Evaluating 24-Hour Subcutaneous Infusion of the GLP-1 Analogue Liraglutide Delivered via the H-Patch Wearable Device
por: Barnes, Jessica W, et al.
Publicado: (2020)

SUN-146 Glucose Clearance (GLCL) Using Continuous Glucose Monitoring (CGM)
por: Melish, John
Publicado: (2019)

OR05-1 Genetic Discovery and Translational Decision Support from Exome Sequencing of 45,231 Type 2 Diabetes Cases and Controls from Five Ancestries
por: Udler, Miriam, et al.
Publicado: (2019)

MON-639 Melanocortin 4 Receptor Contributes to Glucose Homeostasis by Regulating Kidney Glucose Reabsorption via the Glucose Transporter GLUT2
por: de Souza Cordeiro, Leticia M, et al.
Publicado: (2020)

OR22-5 Sotagliflozin Decreases Postprandial Glucose and Insulin by Delaying Intestinal Glucose Absorption
por: Powell, David, et al.
Publicado: (2019)

MON-183 Comparison of Continuous Glucose Monitor versus Meal Tolerance Test for Detection of Post-Bariatric Surgery Hypoglycemia
por: Lee, Clare, et al.
Publicado: (2019)

OR26-01 Epinephrine Is Essential for Normal Renal Glucose Reabsorption via the Glucose Transporter GLUT2
por: Elsheikh, Arwa Mahmoud, et al.
Publicado: (2020)

SAT-146 Short-Term Optimization of Glucose Control Using Self-Monitored Blood Glucose and Standard Therapies
por: Zelada, Henry, et al.
Publicado: (2019)

MON-LB030 Muscle Mitochondrial Oxidative Phosphorylation Capacity and Whole Body Glucose Metabolism in Friedreich's Ataxia
por: Nguyen, Sara, et al.
Publicado: (2019)

OR05-5 AZP-3404, a 9-Amino Acid Peptide Analog of Insulin-Like Growth Factor-Binding Protein 2, Reverses Insulin Resistance in Leptin-Deficient ob/ob Mice
por: Milano, Stephane, et al.
Publicado: (2019)

SUN-LB035 Blood Glucose Trends Documented by Continuous Glucose Monitors Can Be Foundational in the Diagnostic Evaluation of MODY 2
por: Addala, Ananta, et al.
Publicado: (2019)

SAT-127 Hypoglycemic Episodes in Type 2 Diabetes Mellitus : Continuous Glucose Monitoring Versus Self Monitoring of Blood Glucose
por: Aung, Tin, et al.
Publicado: (2019)

OR26-07 Mild Physiologic Hyperglycemia Does Not Affect Glucose Mediated but Impairs Insulin-Mediated Suppression of Plasma Glucagon in Healthy Normal Glucose Tolerant Subjects
por: Tripathy, Devjit, et al.
Publicado: (2020)

MON-635 FDXR Regulates Iron Metabolism and Glucose Metabolism in Liver
por: Sakuma, Ikki, et al.
Publicado: (2020)

Renal GLUT2 is Essential in Regulating Systemic Glucose Homeostasis by Glycosuria
por: de Souza Cordeiro, Leticia M, et al.
Publicado: (2021)

Clinical Utility of 30-Min Postload Plasma Glucose in Paediatric Obesity
por: Poon, Sarah Wing-yiu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_k75npdsoq90l0lhrq4bmag9ad3